Open AccessPB2119: LONG‐TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE‐TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)
Author(s) -
Hamadani M.,
Graham C. N.,
Liao L.,
Zhang K. H.,
Strat H.,
Ungar D.,
Ai W.,
Chen L.,
CarloStella C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851308.42232.1f
Subject(s) - survival analysis , proportional hazards model , population , medicine , hazard ratio , statistics , mathematics , confidence interval , environmental health